Top Dividend Stocks To Watch For 2016

Top Dividend Stocks To Watch For 2016: Smith & Nephew SNATS Inc.(SNN)

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the orthopaedics, endoscopy, and advanced wound management sectors worldwide. The company operates in three segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The Orthopaedics segment offers reconstruction implants, including hip, knee, and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures; and clinical therapies products comprising bone growth stimulation, joint fluid therapies, and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs, and value-added services for sur geons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualisation; radiofrequency wands, electromechanical and mechanical blades, and hand instruments for resecting damaged tissues. The Advanced Wound Management segment provides initial wound bed preparation and full wound closure products. This segment?s products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, including burns and invasive surgery. The company serves medical and surgical service providers. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

Advisors' Opinion:

• [By Kevin Godbold]

  ! So this series aims to identify appealing FTSE 100 investment opportunities and today I'm looking atSmith & Nephew (LSE: SN  ) (NYSE: SNN  ) , the medical devices company.

• [By Dan Carroll]

  British device maker Smith & Nephew (NYSE: SNN  ) is the latest companyto join the emerging markets push. The company announced it agreed to buy Indian trauma device maker Adler Mediequip, which -- along with the buyout of a Braziliandistribution partner -- totaled around $70 million. What does this mean for your investment and the medical device industry's emerging markets momentum?

• [By Teresa Rivas]

  Smith & Nephew ADRs (SNN) were jumping more than 10% on Tuesday afternoon, on anonymous reports that Stryker (SYK) would make a bid for the U.K. firm well above current levels.

  Sources close to the situation say that Stryker is willing to pay as much as a 30% premium to Smith & Nephews current price to acquire the medical device company, and a deal could be announced in the coming weeks, according to Bloombergs Manuel Baigorri, David Welch and Dinesh Nair:

  The bid is still being finalized and the timing could change, said the people. Theres also a chance that Stryker decides against an offer, one of them said. Representatives for Stryker and Smith & Nephew declined to comment.

  However, any shareholders hoping that Stryker might lower its tax bill from a deal will be disappointed: The sources say that given recent scrutiny about corporate inversionswhich has caused other health care names to back off similar plans, including Walgreen (WAG)Stryker isnt considering moving its headquarters overseas to a more favorable tax climate. Late last month, Bloomberg reported that Stryker was mulling an offer that would include an inversion.

  Nonetheless, a combined company would have greater negotiating heft with health insurance companies and hospitals that are under pressure to keep costs down.

  B! arrons.co! m recently recommended shares of Stryker, writing that M&A, including a possible deal with Smith & Nephew, would help the company grow profits.

  Shares of Stryker were up 1.6% at recent check, near multiyear highs.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-dividend-stocks-to-watch-for-2016.html